Otolaryngology Doctors in Mc Lean, VA Accepting Medicare

5 Otolaryngology doctors found. Showing 1 - 5

Dr. Heath Franklin Dreyfuss, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 6845 Elm St, Suite 303, Mc Lean, VA 22101 Phone: 703-448-0005    Fax: 730-448-0808

Alidad Arabshahi, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 1450 Emerson Ave Apt 402, Mc Lean, VA 22101 Phone: 703-988-7562    Fax: 703-660-4803

Marco Aurelio Merida, M.D. Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 7216 Farm Meadow Ct, Mc Lean, VA 22101 Phone: 703-606-3539

Dr. Vartan Mardirossian, M.D. Otolaryngology - Facial Plastic Surgery Medicare: Not Enrolled in Medicare Practice Location: 1401 Chain Bridge Rd Ste 201, Mc Lean, VA 22101 Phone: 703-260-8291    Fax: 703-691-5002

Dr. Joshua A Thompson, M.D. Otolaryngology Medicare: Medicare Enrolled Practice Location: 6845 Elm St Ste 303, Mc Lean, VA 22101 Phone: 703-448-0005

News Archive

Moffitt scientists examine why prostate cancer patients who receive ADT experience hot flashes

Androgen deprivation therapy (ADT) is a common treatment option for patients with advanced stage prostate cancer. But nearly 80 percent of patients who receive ADT report experiencing hot flashes during and after treatment. Moffitt Cancer Center researchers are working to determine what genetic factors and other characteristics might make prostate cancer patients more likely to experience hot flashes during and after therapy.

Simple treatments for Ebola patients not given sufficient priority

The widespread misconception that there are no proven treatments for Ebola virus disease has meant that simple treatments – especially intravenous fluids and electrolytes, which could reduce the number of deaths caused by the virus – have been neglected, according to a new Comment, published in The Lancet.

Innovative breath collecting device could change coronavirus diagnosis around the world

An innovative breath collecting device developed by academics at Northumbria University, Newcastle, could revolutionize the way we diagnose diseases, such as the newly emerged strain of coronavirus, COVID-19.

Randox's Acusera Immunoassay Speciality 1 quality control receives FDA clearance

In Q3 of 2013, Randox announced that the Food and Drug Administration has approved the company's Acusera Immunoassay Speciality 1 quality control for use in US laboratories.

Counseling and shared decision-making can enhance understanding of lung cancer screening

Lung cancer screening using a low-dose CT scan can be a lifesaving test for high-risk patients. While it offers clear benefits, incidental findings and radiation exposure mean there are some potential risks associated with yearly screening.

Read more Medical News

› Verified 6 days ago